R&D
🌏 NMPA Page 2NMPA news and analysis for pharmaceutical BD, investment, and market access · 11 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 13–23 of 23 articles
Acclinate and HCN Global Forge Strategic Partnership to Enhance Clinical Research Diversity
The Pulse of ACC: Honoring Eugene Braunwald and Shaping Cardiology's Future
Illumina's APAC Strategy Under Nilesh Shah: A Competitive Benchmark
How Medicine Forgot Women: A Missed Opportunity for Asia
Newron Pharmaceuticals to Present at Upcoming Investor Conferences
Arcera Life Sciences Partners with Fosun Pharma for Neurodegenerative Disease R&D Collaboration
Samsung Bioepis Partners with ATLATL Innovation Center to Accelerate Asia-Pacific Biotech Development
RFID Technology Market to Reach $15 Billion by 2032, Transforming Pharmaceutical Supply Chain Management
Chitosan Market Surges 14.3% CAGR as KitoZyme, Primex Lead $7.6B Pharmaceutical Biopolymer Boom by 2036
NMPA Grants Breakthrough Therapy Designation to Innovent's KRAS G12C Inhibitor
PMDA Accepts Shionogi Novel Influenza Drug with SAKIGAKE Designation